Industry Corner Live With Synchron CEO Tom Oxley.

Pulse's Industry Corner Live featured a dynamic live Q&A session between IEEE Pulse Editor-in-Chief Chad Andresen and Dr. Tom Oxley, CEO and co-founder of Synchron, a leader in minimally invasive brain-computer interface (BCI) technology. The discussion explored the intersection of neurotechnology, artificial intelligence, and the evolving landscape of entrepreneurship in the MedTech sector. Dr. Oxley shared insights into Synchron's pioneering work with endovascular BCIs, offering a less invasive alternative to traditional neurosurgical approaches, and how this technology is reshaping the possibilities for restoring communication in patients with paralysis. The conversation delved into the growing role of AI in decoding neural signals and driving clinical translation, while also addressing the regulatory, financial, and ethical challenges faced by entrepreneurs in the neurotechnology space. With candid reflections on his journey from clinician to startup founder, Oxley provided an inside look at what it takes to bring disruptive technologies from concept to clinic. This session offered a rare glimpse into the mindset of a neurotech innovator navigating the high-stakes interface of science, medicine, and industry.

Authors

Publication Details

Journal
PubMed
Published
2025-07-16
DOI
https://doi.org/10.1109/mpuls.2025.3572578
Primary Topic
EEG and Brain-Computer Interfaces
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Industry Corner Live With Synchron CEO Tom Oxley.

Chad Anderson
PubMed
EEG and Brain-Computer Interfaces
article

Industry Corner Live With Synchron CEO Tom Oxley.

Chad Anderson
article en

Abstract

Pulse's Industry Corner Live featured a dynamic live Q&A session between IEEE Pulse Editor-in-Chief Chad Andresen and Dr. Tom Oxley, CEO and co-founder of Synchron, a leader in minimally invasive brain-computer interface (BCI) technology. The discussion explored the intersection of neurotechnology, artificial intelligence, and the evolving landscape of entrepreneurship in the MedTech sector. Dr. Oxley shared insights into Synchron's pioneering work with endovascular BCIs, offering a less invasive alternative to traditional neurosurgical approaches, and how this technology is reshaping the possibilities for restoring communication in patients with paralysis. The conversation delved into the growing role of AI in decoding neural signals and driving clinical translation, while also addressing the regulatory, financial, and ethical challenges faced by entrepreneurs in the neurotechnology space. With candid reflections on his journey from clinician to startup founder, Oxley provided an inside look at what it takes to bring disruptive technologies from concept to clinic. This session offered a rare glimpse into the mindset of a neurotech innovator navigating the high-stakes interface of science, medicine, and industry.

PubMedVol. 16(3)
Decent work and economic growth
EEG and Brain-Computer Interfaces
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Industry Corner Live With Synchron CEO Tom Oxley. — Chad Anderson · PubMed (2025) | TGRS Research Map | TGRS